| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Microbiology and Immunology and The Cancer Research Institute, University of California, San Francisco, CA 94143; and
Memorial Sloan-Kettering Cancer Center, New York, NY 10021
CD8+ T cells require a signal through a costimulatory receptor in addition to TCR engagement to become activated. The role of CD28 in costimulating T cell activation is well established. NKG2D, a receptor found on NK cells, CD8+ 
-TCR+ T cells, and 
-TCR+ T cells, has also been implicated in T cell costimulation. In this study we have evaluated the role of NKG2D in costimulating mouse and human naive and effector CD8+ T cells. Unexpectedly, in contrast to CD28, NKG2D engagement by ligand or mAb is not sufficient to costimulate naive or effector CD8+ T cell responses in conventional T cell populations. While NKG2D did not costimulate CD8+ T cells on its own, it was able to modify CD28-mediated costimulation of human CD8+ T cells under certain contitions. It is, therefore, likely that NKG2D acts as a costimulatory molecule only under restricted conditions or requires additional cofactors.
This article has been cited by other articles:
|
|
 |
|
  C. Cerboni, M. Ardolino, A. Santoni, and A. Zingoni Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells Blood, March 26, 2009; 113(13): 2955 - 2964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Tang, Z. Chen, C. Ciszewski, M. Setty, J. Solus, M. Tretiakova, E. Ebert, J. Han, A. Lin, S. Guandalini, et al. Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15 J. Exp. Med., March 16, 2009; 206(3): 707 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Walsh, L. L. Lanier, and T. E. Lane NKG2D Receptor Signaling Enhances Cytolytic Activity by Virus-Specific CD8+ T Cells: Evidence for a Protective Role in Virus-Induced Encephalitis J. Virol., March 15, 2008; 82(6): 3031 - 3044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Sutherland, B. Rabinovich, N. J. Chalupny, P. Brawand, R. Miller, and D. Cosman ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15 Blood, August 15, 2006; 108(4): 1313 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Bui, L. N. Carayannopoulos, L. L. Lanier, W. M. Yokoyama, and R. D. Schreiber IFN-Dependent Down-Regulation of the NKG2D Ligand H60 on Tumors J. Immunol., January 15, 2006; 176(2): 905 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Routes, S. Ryan, K. Morris, R. Takaki, A. Cerwenka, and L. L. Lanier Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection J. Exp. Med., December 5, 2005; 202(11): 1477 - 1482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. L. Teng, M. H. Kershaw, Y. Hayakawa, L. Cerutti, S. M. Jane, P. K. Darcy, and M. J. Smyth T Cells Gene-engineered with DAP12 Mediate Effector Function in an NKG2D-dependent and Major Histocompatibility Complex-independent Manner J. Biol. Chem., November 18, 2005; 280(46): 38235 - 38241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Markiewicz, L. N. Carayannopoulos, O. V. Naidenko, K. Matsui, W. R. Burack, E. L. Wise, D. H. Fremont, P. M. Allen, W. M. Yokoyama, M. Colonna, et al. Costimulation through NKG2D Enhances Murine CD8+ CTL Function: Similarities and Differences between NKG2D and CD28 Costimulation J. Immunol., September 1, 2005; 175(5): 2825 - 2833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Kriegeskorte, F. E. Gebhardt, S. Porcellini, M. Schiemann, C. Stemberger, T. J. Franz, K. M. Huster, L. N. Carayannopoulos, W. M. Yokoyama, M. Colonna, et al. NKG2D-independent suppression of T cell proliferation by H60 and MICA PNAS, August 16, 2005; 102(33): 11805 - 11810. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
